Taken together, our results show that M2 macrophage markers and TIM3/galectin-9/CEACAM1 expression levels are increased in thyroid cancer tissues, thereby supporting our in vitro findings. This evidence concerns the gene HAVCR2 and thyroid gland carcinoma.